Flipping the switch to better see cancer cells at depths

Flipping the switch to better see cancer cells at depths

​A team of engineers, led by Washington University’s Lihong Wang and postdoctoral researcher Junjie Yao, found that by genetically modifying glioblastoma cancer cells to express BphP1 protein, derived from a bacterium commonly found in soil and water, they could clearly see tiny amounts of live cancer cells as deep as 1 centimeter in tissue using photoacoustic tomography.

Master gene orchestrates regeneration of damaged peripheral nerves​

School of Medicine scientists have identified a master gene involved in orchestrating the regrowth of peripheral nerves — the nerves that extend from the spinal column to the hands and feet and have the ability to regenerate and help people regain some movement and sensation. Understanding how these nerves regenerate may aid efforts to regrow spinal cord neurons.

Eye’s recycling process key to seeing color, bright light

The retina’s rods and cones allow us to see. But although scientists have an idea of what makes rods perform and flourish, they’ve been somewhat in the dark regarding what keeps cones working and thriving. Now, School of Medicine researchers led by Thomas A. Ferguson, PhD, believe they’re closer to the answer and that their findings may one day help preserve vision in patients with age-related macular degeneration and other retinal diseases.

Ley receives $6.4 million NCI award for leukemia research​​

​​Timothy J. Ley, MD, a leukemia researcher and hematologist at the School of Medicine, has received a seven-year, $6.4 million Outstanding Investigator Award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The funding will allow him to continue research aimed at understanding the mutations that initiate acute myeloid leukemia (AML), and how they might be targeted with new approaches.
Good as gold​​​​​

Good as gold​​​​​

Researchers at Washington University in St. Louis, led by Srikanth Singamaneni, PhD, associate professor of materials science in the School of Engineering & Applied Science, are using color-shifting nanoparticles of ​gold, combined with specifically engineered artificial antibodies, to detect biochemical signs of kidney damage.​

Methadone’s side effects, efficacy may be linked to genetic makeup​

Methadone — long used to treat pain and addiction — can be lethal if it lingers too long in the body. New research led by the School of Medicine’s Evan D. Kharasch, MD, PhD, has identified genetic subtypes in people that govern methadone clearance, findings that could help prevent some of the 5,000 methadone-related deaths that occur each year in the United States.
Older Stories